Unknown PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT05480631

COMPARATIVE ANALYSIS OF INNOVATIVE BONE HEALING TECHNIQUES

COMPARATIVE ANALYSIS OF INNOVATIVE BONE HEALING TECHNIQUES IN MANDIBLE BONE DEFECTS

Sponsor: Dow University of Health Sciences

Conditions To Assess the Bone Healing in Fracture Mandible Defects

Interventions autograft autograft with addition of concenterated growth factor xenograft with concentrated growth factor

Updated 4 times since 2022 Last updated: Jul 27, 2022 Started: Dec 17, 2020 Primary completion: Jul 20, 2022 Completion: Jul 20, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates To Assess the Bone Healing in Fracture Mandible Defects and is currently ongoing. Dow University of Health Sciences leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Aug 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Sep 2022 — Jul 2024 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dow University of Health Sciences

Data source: Dow University of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan